Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-098488

Chief Operating Officer sold 2,014 shares at $28.93 ($58,265)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gault Cheryl Chief Operating Officer 2026-03-05 Sale −2,014 $28.93 $58,265 169,914 D: show line 1 in the form
Open-market sales · 2,014 sh · avg $28.93 · $58,265
Loading xslF345X05/ownership.xml…